- Home
- KRRO vs MYPS Comparison
KRRO vs MYPS Comparison
Compare KRRO & MYPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRRO
- MYPS
- Stock Information
- Founded
- KRRO 2014
- MYPS 2011
- Country
- KRRO United States
- MYPS United States
- Employees
- KRRO N/A
- MYPS N/A
- Industry
- KRRO Biotechnology: Pharmaceutical Preparations
- MYPS EDP Services
- Sector
- KRRO Health Care
- MYPS Technology
- Exchange
- KRRO Nasdaq
- MYPS Nasdaq
- Market Cap
- KRRO 209.6M
- MYPS 218.2M
- IPO Year
- KRRO 2019
- MYPS N/A
- Fundamental
- Price
- KRRO $13.90
- MYPS $1.28
- Analyst Decision
- KRRO Strong Buy
- MYPS Hold
- Analyst Count
- KRRO 7
- MYPS 6
- Target Price
- KRRO $106.33
- MYPS $2.75
- AVG Volume (30 Days)
- KRRO 110.5K
- MYPS 232.1K
- Earning Date
- KRRO 05-13-2025
- MYPS 05-05-2025
- Dividend Yield
- KRRO N/A
- MYPS N/A
- EPS Growth
- KRRO N/A
- MYPS N/A
- EPS
- KRRO N/A
- MYPS N/A
- Revenue
- KRRO $2,271,000.00
- MYPS $289,429,000.00
- Revenue This Year
- KRRO N/A
- MYPS N/A
- Revenue Next Year
- KRRO $20.00
- MYPS N/A
- P/E Ratio
- KRRO N/A
- MYPS N/A
- Revenue Growth
- KRRO N/A
- MYPS N/A
- 52 Week Low
- KRRO $11.13
- MYPS $1.14
- 52 Week High
- KRRO $98.00
- MYPS $2.55
- Technical
- Relative Strength Index (RSI)
- KRRO 34.42
- MYPS 46.44
- Support Level
- KRRO $12.21
- MYPS $1.23
- Resistance Level
- KRRO $15.30
- MYPS $1.43
- Average True Range (ATR)
- KRRO 2.09
- MYPS 0.10
- MACD
- KRRO 0.21
- MYPS 0.01
- Stochastic Oscillator
- KRRO 38.74
- MYPS 46.43
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
About MYPS PLAYSTUDIOS Inc.
PLAYSTUDIOS Inc is engaged in gaming and related business. The Company develops and operates online and mobile social gaming applications (games or game), many of which incorporate a loyalty program offering real world rewards provided by a collection of awards partners. The Company's games are free-to-play and available via the Apple App Store, Google Play Store, Amazon Appstore, and Facebook (collectively, platforms or platform operators). The Company creates games based on its own original content as well as third-party licensed brands. The Company generates revenue through the in-game sales of virtual currency and through advertising. The company has one operating segment with one business activity, developing and monetizing social games.